By Turna Ray
The US Food and Drug Administration's decision last month to explore risk-based strategies to regulate all laboratory-developed tests didn't come as a surprise to most players in the molecular diagnostic industry.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now. Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
In PLOS this week: new gene linked to ocular coloboma, new statistical model for interrogating gene expression networks, and more.
With a new collection, PLOS highlights negative results it has published.
A pair of researchers examines political leanings and views on genomics, finding more of a role for optimism and pessimism in people's views.
The genome of the carnivorous bladderwort is smaller than many other plant genomes, but it still holds on to important genes.